已收盘 03-27 16:00:00 美东时间
-0.100
-0.19%
(来源:经济日报) 转自:经济日报 近日,葛兰素史克(GSK)与科园信海(北京)医疗用品贸易有限公司(简称“上药科园贸易”)在上海举行战略合作启动仪式,宣布双方...
今天 14:36
据国家药监局消息,近日,国家药品监督管理局批准GlaxoSmithKline Trading Services Limited申报的德莫奇单抗注射液(商品名:易...
03-27 17:59
Wave Life Sciences stock drops after INLIGHT Phase 1 data. WVE-007 shows fat reduction, lean mass stability, and biomarker suppression.
03-26 23:25
GlaxoSmithKline ( ($GB:GSK) ) just unveiled an update. GSK disclosed that Maya ...
03-25 23:32
Recursion (Nasdaq: RXRX) said on Wednesday that it had named Vicki Goodman as chief medical officer, effective April 6, 2026, succeeding David Mauro. Goodman had more than two decades of experience in...
03-25 20:44
• GSK的RSV疫苗获FDA扩大批准,适用于高风险成年人群。 • 一款在研抗癌药物在日本获得孤儿药认定。 • 分析师维持“买入”评级,理由是不确定性缓解和增长指引。
03-25 19:17
新京报讯(记者王卡拉)3月24日,葛兰素史克(GSK)在上海与科园信海(北京)医疗用品贸易有限公司(以下简称“上药科园贸易”)签署战略合作协议,双方将基于既有的...
03-25 19:17
携手上药科园贸易共筑坚实健康屏障 上海2026年3月25日 /美通社/ -- 3月24日,全球领先的疫苗企业葛兰素史克(LSE/NYSE: GSK)在上海与科园...
03-25 17:51
Recursion announced that Dr. Vicki Goodman will replace Dr. David Mauro as its Chief Medical Officer. Dr. Goodman brings extensive oncology and clinical development expertise, including roles at Exelixis, Merck, and Bristol Myers Squibb, and experience as an FDA reviewer. Her leadership will support Recursion's clinical pipeline and regulatory milestones. Dr. Mauro will transition out of his role after three years, with Najat Khan expressing grat...
03-25 11:59
(来源:抗体圈) 行业格局逆转:从普遍扩张到集体收缩 对比近年数据,制药行业用人策略出现根本性反转。2022 年,17 家大型药企中仅 3 家启动裁员;到...
03-24 15:34